Structured evidence table for Tocotrienols Blood Pressure Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Tocotrienols Blood Pressure Meta-Analysis | 1 2 3 4 5 6 In the general population, subjective memory complaints (SMC) are associated with a reduced global quality of life, increased risk of depression, and negative impact on daily living activities (,). | 2 | Lopresti Adrian L. (2025) | An examination into the effects of tocotrienols (TheraPrimE® rice) on cognitive abilities and sleep in healthy adults: a randomised, double-blind, placebo-controlled trial |
| Tocotrienols Blood Pressure Meta-Analysis | Research also suggests that SMC in middle age is a concern as it is associated with cortical thinning in brain regions affected by Alzheimer’s disease (AD) and poorer performance on objective memory tests (). | 2 | Lopresti Adrian L. (2025) | An examination into the effects of tocotrienols (TheraPrimE® rice) on cognitive abilities and sleep in healthy adults: a randomised, double-blind, placebo-controlled trial |
| Tocotrienols Blood Pressure Meta-Analysis | Memory complaints are distressing for adults of all ages and are associated with greater negative affect (,). | 2 | Lopresti Adrian L. (2025) | An examination into the effects of tocotrienols (TheraPrimE® rice) on cognitive abilities and sleep in healthy adults: a randomised, double-blind, placebo-controlled trial |
| Tocotrienols Blood Pressure Meta-Analysis | Older people with SMC are twice as likely to develop dementia compared to individuals without SMC. | 2 | Lopresti Adrian L. (2025) | An examination into the effects of tocotrienols (TheraPrimE® rice) on cognitive abilities and sleep in healthy adults: a randomised, double-blind, placebo-controlled trial |
| Tocotrienols Blood Pressure Meta-Analysis | The underlying pathology of glaucoma is largely attributed to impaired aqueous humor drainage, primarily through the trabecular meshwork and Schlemm’s canal, leading to increased IOP.This elevated pressure exerts mechanical stress on the optic nerve, compromising its blood supply and resulting in retinal ganglion cell (RGC) apoptosis, a hallmark of glaucoma-induced vision loss. | 3 | Latib Fazira (2025) | Therapeutic Potential of Tocopherol and Tocotrienol in Glaucoma Management |
| Tocotrienols Blood Pressure Meta-Analysis | The socioeconomic impact of glaucoma is profound, as vision impairment leads to reduced quality of life, increased healthcare costs, and a growing burden on caregivers and public health systems.Current glaucoma management primarily focuses on lowering IOP through pharmacological agents, laser therapy, or surgical interventions. | 3 | Latib Fazira (2025) | Therapeutic Potential of Tocopherol and Tocotrienol in Glaucoma Management |
| Tocotrienols Blood Pressure Meta-Analysis | As a result, causes cytoskeletal destabilization, degrade axonal structural proteins, disrupt mitochondrial function, and irreversible axon fragmentation. | 3 | Latib Fazira (2025) | Therapeutic Potential of Tocopherol and Tocotrienol in Glaucoma Management |
| Tocotrienols Blood Pressure Meta-Analysis | 1 2 Glaucoma is a leading cause of irreversible blindness worldwide, characterized by progressive optic nerve damage that often results from elevated intraocular pressure (IOP). | 3 | Latib Fazira (2025) | Therapeutic Potential of Tocopherol and Tocotrienol in Glaucoma Management |
Source documents